FDA approves VIASYS' high frequency ventilator:
This article was originally published in Clinica
Executive Summary
The US FDA has approved VIASYS Healthcare's high frequency oscillatory ventilator for treating acute respiratory failure in adults and large children. The SensorMedics 3100B device uses higher distending pressures than conventional ventilators to open the diseased lung units and improve the delivery of oxygen, says the Conshohocken, Pennsylvania firm. It then uses very rapid, small breaths to remove carbon dioxide, thereby reducing injury to the lungs. A paediatric version of the device was launched in 1991.
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.